Mitochondrial disorders

Current Opinion in Neurology

Volumn 9, Issue 5, 1996, Pages 369-374

  Moraes, Carlos T ^a  

^a UNIVERSITY OF MIAMI   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MITOCHONDRIAL DNA; PROTEIN; TRANSFER RNA;

AGING; DEGENERATIVE DISEASE; DISORDERS OF MITOCHONDRIAL FUNCTIONS; ENDOCRINE DISEASE; EYE DISEASE; GASTROINTESTINAL DISEASE; GENE; HUMAN; MENTAL DISEASE; MUTATION; NEUROMUSCULAR DISEASE; NUCLEOTIDE SEQUENCE; OXIDATIVE PHOSPHORYLATION; REVIEW;

EID: 0029963711     PISSN: 13507540     EISSN: None     Source Type: Journal    
DOI: 10.1097/00019052-199610000-00010     Document Type: Review

References (49)

1. Anderson S, Bankier AT, Barrell BG, de Bruijn MHL, Coulson AR, Drouin J, Eperon IC, Nierlich DP, Roe BA, Sanger F et al: Sequence and organization of the human mitochondrial genome. Nature 1981, 290:457-465
2. Larsson NG, Clayton DA: Molecular genetics aspects of human mitochon-drial disorders. Annu Rev Genet 1995, 29:151-178.
3. Ernster L, Luft R, Orrenius S (eds): Nobel Symposium 90: mitochondrial diseases. Biochim Biophys Acta 1995, 1271:1-286.
4. Salmaggi A, Carrara F, Zeviani M: Remarkable recovery of visual function In a patient with Leber's optic neuropathy and multiple mutations of mitochondrial DNA. Int J Neurosci 1994, 77:261-266.
5. Jun AS, Trounce IA, Brown MD, Shoffner JM, Wallace DC: Use of transmitochondrial • cybrlds to assign a complex I defect to the mitochondrial DNA-encoded NADH dehydrogenase subunit 6 gene mutation at nucleotide pair 14459 that causes Leber hereditary optic neuropathy and dystonia. Mol Cell Biol 1996, 16:771-777 The authors demonstrate a complex I deficiency associated with the LHON/ dystonia mutation in the WD6 gene.
6. Shoffner JM, Brown MD, Stugard C, Jun AS, Pollock S, Haas RH, Kaufman A, Koontz D, Kim Y, Graham JR, Wallace DC: Leber's hereditary optic neuropathy plus dystonia is caused by a mitochondrial DNA point mutation. Ann Neurol 1995, 38:163-169.
7. Thyagarajan D, Shanske S, Vazquez-Memije M, De Vivo D, DiMauro S: A novel mitochondrial ATPase 6 point mutation in familial bilateral strlatal necrosis. Ann Neurol 1995, 38:468-472.
8. Keightley JA, Hoffbuhr KC, Buton MD, Salas VM, Johnston WSW, Penn AMW, • Buist NRM and Kennaway NG: A microdeletion in cytochrome c oxidase (COX) subunit III associated with COX deficiency and recurrent myoglobinuria. Nat Genet 1996, 12:410-416. A well documented description of a gene-specific deletion of 15 bp (the smallest 'more than one nucleotide' mtDNA deletion to be associated with human disease).
9. Casali C, Santorelli FM, D'Amati G, Bernucci P, DeBiase L, DiMauro S: A novel mtDNA point mutation in maternally inherited cardiomyopathy. Biochem Biophys Res Commun 1995, 213:588-593.
10. Hanna MG, Nelson I, Sweeney MG, Cooper JM, Watkins PJ, Morgan-Hughes JA, Harding AE: Congenital encephalomyopathy and adult-onset myopathy and diabetes mellitus: different phenotypic associations of a new heteroplasmlc mtDNA tRNA glutamic acid mutation. Am J Hum Genet 1995, 56:1026-1033.
11. Hao H, Bonilla E, Manfredi G, DiMauro S, Moraes CT: Segregation patterns of a novel mutation in the mitochondrial tRNA glutamic acid gene associated with myopathy and diabetes mellitus. Am J Hum Genet 1995, 56:1017-1025.
12. Manfredi G, Schon EA, Bonilla E, Moraes CT, Shanske S, DiMauro S: Identification of a mutation in the mitochondrial tRNA-cys gene associated with mitochondrial encephalomyopathy. Hum Mut 1996, 7.158-163.
13. Nakamura M, Nakano S, Goto Y, Ozawa M, Nagahama Y, Fukuyama H, Akiguch I, Kaji R, Kimura J: A novel point mutation in the mitochondria tRNA [Ser (UCN)] gene detected in a family with MERRF/MELAS overlap syndrome. Biochem Biophys Res Commun 1995, 214:86-93.
14. Santorelli FM, Mak SC, El-Schahawi M, Casali C, Shanske S, Baram TZ, Madrid RE, DiMauro S: Maternally inherited cardiomyopathy and hearing loss associated with a novel mutation in the mitochondrial tRNALys gene (G8363A). Am J Hum Genet 1996, 58:933-939.
15. Santorelli FM, Mak SC, Vazques-Acevedo M, Gonzalez-Astiazaran A, Ridaura-Sanz C, Gonzalez-Halphen D, Di Mauro S: A novel mitochondrial DNA point mutation associated with mitochondrial encephalocardiomyopathy. Biochem Biophys Res Commun 1995, 216:835-840.
16. Tiranti V, Chariot P, Carella F, Toscano A, Soliveri P, Girlanda P, Carrara F, Fratta GM, Reid FM, Mariotti C, Zeviani M: Maternally Inherited hearing loss, ataxia and myoclonus associated with a novel point mutation in mitochondrial tRNASer(UCN) gene. Hum Mol Genet 1995, 4:1421-1427
17. Nelson I, Hanna MG, Alsanjari N, Scaravilli F, Morgan-Hughes JA, Harding AE: A new mitochondrial DNA mutation associated with progressive dementia and chorea: a clinical, pathological, and molecular genetic study. Ann Neurol 1995, 37:400-403.
18. Bourgeron T, Rustin P, Chretien D, Birch-Machin M, Bourgeois M, Viegas-•• Pequignot E, Munnich A, Rotig A: Mutation of a nuclear succinate dehydrogenase gene results in mitochondrial respiratory chain deficiency. Nat Genet 1995, 11:144-149. The first well documentated description of a nuclear DNA mutation affecting oxidative phosphorylation system components.
19. Suomalainen A, Kaukonen J, Amati P, Timonen R, Haltia M, Weissembach J, •• Zeviani M, Somer H, Peltonen L: An autosomal locus predisposing to deletions of mitochondrial DNA. Nat Genet 1995, 9:146-151. The first report of a nuclear DNA locus linked to multiple mtDNA deletions in autosomal dominant PEO.
20. Kaukonen JA, Amati P, Suomalainen A, Rotig A, Piscaglia MG, Salvi F, •• Weissenbach J, Fratta G, Comi G, Peltonen L, Zeviani M: An autosomal locus predisposing to multiple deletions of mtDNA on chromosone 3p. Am J Hum Genet 1996, 58:763-769. Identified a second locus linked to autosomal dominant PEO with multiple mtDNA deletions.
21. Wallace DC, Lott MT, Brown MD, Huoponen K, Tomni A: Report of the cornmittee on human mitochondrial DNA. In Human gene mapping 1995: a compendium. Edited by Cuticchia AJ. Baltimore: Johns Hopkins University Press; 1995:910-954 (also available at http://www.gen.emory.edu/mitomap. html).
22. Lys gene are associated with the presence of abnormal mitochondnally-synthesized polypeptides.
23. Lys.
24. Sparaco M, Schon EA, DiMauro S, Bonilla E: Myoclonic epilepsy with • ragged-red fibers (MERRF): an immunohistochemical study of the brain. Brain Pathol 1995, 5:125-133. This study pioneered the molecular approaches extensively used in muscle to brain tissue.
25. Hao H, Moraes CT: Functional and molecular mitochondrial abnormalities • associated with a C→T transition at position 3256 of the human mitochondrial genome. J Biol Chem 1996, 271:2347-2352. Identified a specific reduction in the synthesis of ND1 polypeptide caused by misprocessing of an intermediate transcript (RNA 19).
26. Mariotti C, Uziel G, Carrara F, M. M, Prelle A, Tiranti V, DiDonato S, Zeviani M Early-onset encephalomyopathy associated with tissue-specific mitochondrial DNA depletion: a morphological, biochemical and moleculargenetic study. J Neurol 1995, 242:547-556.
27. Bodnar AG, Cooper JM, Leonard JV, Schapira AH: Respiratory-deficient • human fibroblasts exhibiting defective mitochondrial DNA replication. Biochem J 1995, 305:817-822. Genetic and biochemical characterization of patient-derived cell lines that spontaneously lose their mtDNA in culture.
28. Poulton J, Sewry C, Potter CG, Bougeron T, Chretian D, Wijburg FA, Morten KJ, Brown G: Variation in mitochondrial DNA levels in muscle from normal controls. Is depletion of mtDNA in patients with mitochondrial myopathy a distinct clinical syndrome. J Inher Met Dis 1995, 18:4-20.
29. Tiranti V, Munaro M, Sandona D, Lamantea E, Rimoldi M, DiDonato S, Bisson • R, Zeviani M: Nuclear DNA origin of cytochrome c oxidase deficiency in Leigh's syndrome: genetic evidence based on patient's-derived rho degrees transformants. Hum Mol Genet 1995, 4:2017-2023. Pioneered the use of patient-derived cells without mtDNA to investigate the genetic origin of an oxidative phosphorylation system defect.
30. Poulton J, Morten KJ, Marchington D, Weber K, Brown GK, Rotig A, Bindoff L: Duplications of mitochondrial DNA in Kearns-Sayre syndrome. Muscle Nerve 1995, (suppl 3):154-158.
31. Manfredi G, Servidei S, Bonilla E, Shanske S, Schon EA, DiMauro S, Moraes CT: High levels of mitochondrial DNA with an unstable 260-bp duplication in a patient with a mitochondrial myopathy. Neurology 1995, 45: 762-768.
32. Chen X, Prosser R, Simonetti S, Sadlock J. Jagiello G, Schon EA: Rearranged • mitochondrial genomes are present in human oocytes. Am J Hum Genet 1995, 57:239-247. Shows that partially-deleted mtDNA exist in human oocytes. This observation has many important implications for the accumulation of mtDNA deletions during aging.
33. Bohlega S, Tanji K, Santorelli FL, Hirano M, al-Jashi A, DiMauro S: Multiple mtDNA deletions associated with autosomal recessive ophthalmoplegia and severe cardiomyopathy. Neurology 1996, 46:1329-1334.
34. Rifai Z, Welle S, Kamp C, Thornton CA: Ragged-red fibers in normal aging and inflammatory myopathy. Ann Neurol 1995, 37:24-29.
35. Johnston W, Karpati G, Carpenter S, Arnold D, Shoubridge EA: Late-onset mitochondrial myopathy. Ann Neurol 1995, 37:16-23.
36. Oldfors A, Moslemi AR, Fyhr IM, Holme E, Larsson NG, Lindberg C: Mitochondrial • DNA deletions In muscle fibers in Inclusion body myositis. J Neuropathol Exp Neurol 1995, 54:581-587. Shows that patients with inclusion body myositis have RRF caused by an expansion of specific mtDNA deletions. Different RRF have different mtDNA deletions.
37. Hutchin T, Cortopassi G: A mitochondrial DNA clone is associated with Increased risk for Alzheimer disease. Proc Natl Acad Sci USA 1995, 92:6892-6895.
38. Shoffner JM, Brown MD, Torrina A, Lott MT, Cabell MF, Mirra SS, Beal MF, Yang CC, Gearing M, Salvo R: Mitochondrial DNA variants observed In Alzheimer disease and Parkinson disease patients. Genomics 1993, 17:171-184.
39. Wragg MA, Talbot CJ, Morris JC, Lendon CL, Gloate AM: No association found between Alzheimer's disease and a mitochondrial tRNA glutamine gene variant Neurosci Lett 1995, 201:107-110.
40. Brown MD, Shoffner JM, Kim YL, Jun AS, Grahan BH, Cabell MF, Gurley DS, Wallace DC: Mitochondrial DNA sequence analysis of four Alzheimer's and Parkinson's patients. Am J Med Genet 1996, 61:283-289.
41. Walker UA, Byrne E: The therapy of respiratory chain encephalomyopathy: a critical review of the past and current perspective. Acta Neurol Scand 1995, 92:273-280.
42. DeStefano N, Matthews PM, Ford B, Genge A, Karpati G, Arnold DL: Short-term dichloroacetate treatment Improves indices of cerebral metabolism in patients with mitochondrial disorders. Neurology 1995, 45:1193-1198.
43. Taivassalo T, De Stefano N, Matthews PM, Karpati G, Genge A, Arnold DL: Aerobic training and dichloroacetate treatment improve biochemical and functional parameters In patients with mitochondrial myopathy [Abstract]. Neurology 1996, 46(suppl):A421.
44. Wallace DC, Fleming N, Krawiecki N, Yeager AM, Shoffner JM: Granulocyte colony stimulating factor and erythropietin therapy In Pearson's syndrome [Abstract]. Neurology 1996, 46(suppl):A421.
45. Peterson PL: The treatment of mitochondrial myopathies and encephalomyopathies. Biochim Biophys Acta 1995, 1271:275-280.
46. Barbiroli B, Medori R, Tritschler H-J, Klopstock T, Seibel P, Reichmann H, lotti S, Lodi R, Zaniol P: Lipoic (thioctic) acid Increases brain energy availability and skeletal muscle performances as shown by in vivo 31P-MRS in a patient with mitochondrial cytopathy. J Neurol 1995, 242: 472-477.
47. Seibel P, Trappe J, Villani G, Klopstock T, Papa S, Reichmann H: Transfection • of mitochondria: strategy towards a gene therapy of mitochondria DNA diseases. Nuc Acids Res 1995, 23:10-17. This group demonstrated the feasibility of importing double-stranded DNA fragments into mitochondria through the protein import pathway.
48. Vestweber D, Schatz G: DNA-protein conjugates can enter mitochondria via the protein Import pathway. Nature 1989, 338:170-172.
49. Attardi GM, Chomyn A: Mitochondrial biogenesis and genetics (part B). •• Methods Enzymol 1996, 264:3-621. One of two volumes compiling many methodological descriptions written by experts in the field. A 'must have' for laboratories working on mitochondrial genetics, biogenesis or disease.